Pharma-Funded FDA Gets Drugs Out Faster, But Some Work Only ‘Marginally’ and Most Are Pricey
Since pharmaceutical companies started funding their FDA drug applications 30 years ago, the agency’s reviews have gone much faster — perhaps too fast.
Journalists Dig In on the Fiscal Health of the Nation and Hospital Closures in Rural Missouri
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Sports Programs in States in Northern Climes Face a New Opponent: Scorching Septembers
Montana and many other states in the northern U.S. have not updated their policies to keep young athletes safe from heatstroke amid rising temperatures.
Listen: Grieving Families Face the Cruelest Bills
KHN Midwest correspondent Lauren Weber talks with NPR's "Consider This" podcast about her reporting on families confronted with medical bills while grieving the loss of a baby who received expensive hospital care.
Turned Away From Urgent Care — And Toward a Big ER Bill
Russell Cook was expecting a quick and inexpensive visit to an urgent care center for his daughter, Frankie, after she had a car wreck. Instead, they were advised to go to an emergency room and got a much larger bill.
KHN’s ‘What the Health?’: On Government Spending, Congress Decides Not to Decide
Congress has once again decided not to decide how to fund the federal government in time for the start of the fiscal year, racing toward a midnight Sept. 30 deadline to pass a stopgap bill that would keep the lights on for two more months. However, it does appear the FDA’s program that gets drugmakers to help fund some of the agency’s review staff will be renewed in time to stop pink slips from being sent. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat, and Victoria Knight of Axios join KHN’s Julie Rovner to discuss these topics and more. Also this week, Rovner interviews filmmaker Cynthia Lowen, whose new documentary, “Battleground,” explores how anti-abortion forces played the long game to overturn Roe v. Wade.
Centene Agrees to Pay Massachusetts $14 Million Over Medicaid Prescription Claims
Massachusetts is the latest state to settle with St. Louis-based Centene Corp. over allegations that it overcharged Medicaid prescription drug programs.
